Efforts are underway to develop countermeasures to prevent the environmental spread of
COVID-19 pandemic caused by SARS-CoV-2. Physical decontamination methods like …

The ongoing COVID‐19 pandemic is caused by SARS‐CoV‐2. Although several effective
vaccines that target the Spike protein on the viral surface have been deployed, additional …

Abstract Coxsackievirus B1 (CVB1) is a major pathogen that causes viral myocarditis and
aseptic meningitis and is implicated as a cause of type 1 diabetes mellitus. The rapid …

The emergence of viral outbreaks has posed a great human threat and severely affected
communities, public health infrastructures, and economies globally. In the last 20 years, the …

The outbreak of COVID-19 has become a public health emergency of international concern;
thus, it is important to not only develop drugs for treating COVID-19 but also develop a …

The use of monoclonal neutralizing antibodies (mNAbs) is being actively pursued as a
viable intervention for the treatment of Severe Acute Respiratory Syndrome CoV-2 (SARS …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
global pandemic of coronavirus disease 2019 (COVID-19), causing over 6.6 million deaths …

ABSTRACT SARS-COV-2 antibodies in patients candidates as donors of immune plasma.
Background: in this study SARS-CoV-2 serology was investigated, using three different …

Aims: This case-control prospective study aimed to describe the effects of COVID
convalescent plasma (CCP) on late mortality in hospitalized patients with coronavirus …

The global deployment of an effective and safe vaccine is currently a public health priority to
curtail the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute …